In this review, we summarize current evidence relating to the expression and function of intestinal BTRs in relation to enteroendocrine hormone release, as well as the clinical implications of this pathway for the management of obesity and type 2 diabetes
Individualising Care: Choosing the Right GLP-1RA for the Right Patient Not All GLP-1RAs are Made Equal GLP-1RAs are often differentiated according to structure and duration of action (Table 2) [9, 24, 45,46,47,48]
Rekha Kumar, chief medical officer at the medically supported weight care program Found and a practicing endocrinologist in New York City, advises her patients to stop taking semaglutide-containing medications in the months leading up to pregnancy
By Chrissie Ott, MD Summer 2026 As a physician, coach and mother, Ive learned that conversations about Read Article By Ankit Kushwaha, MD, FACP Summer 2026 Asthma and obesity are two of the most common Read Article By Sarah Bramblette, MSHL, OAC Senior Advocacy Manager Summer 2026 Several years ago, I was offered Read Article
Thats why your journey starts with a comprehensive consultation to determine the best option for your unique body, goals, and lifestyle